Monoclonal gammopathy-associated thrombotic microangiopathy.
作者信息
Yui Jennifer C, Garceau Daniel, Jhaveri Kenar D, Wanchoo Rimda, Bijol Vanesa, Glezerman Ilya, Hassoun Hani, Dispenzieri Angela, Russell Stephen J, Leung Nelson
机构信息
Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Service of Nephrology, IUCPQ, Quebec City, Quebec, Canada.
出版信息
Am J Hematol. 2019 Oct;94(10):E250-E253. doi: 10.1002/ajh.25569. Epub 2019 Jul 17.
Abstract
摘要
相似文献
1
Monoclonal gammopathy-associated thrombotic microangiopathy.
Am J Hematol. 2019 Oct;94(10):E250-E253. doi: 10.1002/ajh.25569. Epub 2019 Jul 17.
2
Thrombotic microangiopathy associated with monoclonal gammopathy.
Kidney Int. 2017 Mar;91(3):691-698. doi: 10.1016/j.kint.2016.09.045. Epub 2016 Dec 18.
3
Crystalglobulinemia manifested as acute renal failure and thrombotic vasculopathy.
Rheumatol Int. 2020 Aug;40(8):1327-1332. doi: 10.1007/s00296-020-04620-6. Epub 2020 Jun 12.
4
Thrombotic microangiopathy with intraglomerular IgM pseudothrombi in Waldenström macroglobulinemia and IgM monoclonal gammopathy.
J Nephrol. 2018 Dec;31(6):907-918. doi: 10.1007/s40620-018-0544-9. Epub 2018 Oct 17.
5
[Renal failure caused by plasma cell dyscrasia].
Nihon Rinsho. 1992 Jan;50 Suppl:30-6.
6
Renal lesions in dysproteinemias.
Springer Semin Immunopathol. 1982;5(3):333-56. doi: 10.1007/BF01892092.
7
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
BMC Nephrol. 2014 Sep 30;15:156. doi: 10.1186/1471-2369-15-156.
8
De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors.
Exp Clin Transplant. 2016 Apr;14(2):230-4. doi: 10.6002/ect.2014.0089. Epub 2015 May 30.
9
Acute Kidney Injury in a Patient With Monoclonal Gammopathy.
Am J Kidney Dis. 2020 Dec;76(6):A10-A12. doi: 10.1053/j.ajkd.2020.05.033.
10
[Neurologic manifestations of monoclonal gammapathies].
Schweiz Med Wochenschr. 1984 Nov 24;114(47):1678-85.
引用本文的文献
1
Recommendations for diagnosis and treatment of Atypical Hemolytic Uremic Syndrome (aHUS): an expert consensus statement from the Rare Diseases Committee of the Brazilian Society of Nephrology (COMDORA-SBN).
J Bras Nefrol. 2025 Apr-Jun;47(2):e20240087. doi: 10.1590/2175-8239-JBN-2024-0087en.
2
Management of hematological patients requiring emergency chemotherapy in the intensive care unit.
Intensive Care Med. 2024 Jun;50(6):849-860. doi: 10.1007/s00134-024-07454-z. Epub 2024 May 15.
3
Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study.
Sci Rep. 2024 Apr 1;14(1):7667. doi: 10.1038/s41598-024-58467-z.
4
The spectrum of thrombotic microangiopathy related to monoclonal gammopathy.
Clin Kidney J. 2024 Jan 8;17(1):sfad306. doi: 10.1093/ckj/sfad306. eCollection 2024 Jan.
5
Case report: A case of new mutation in leading to thrombotic microangiopathy.
Front Genet. 2023 Sep 27;14:1278511. doi: 10.3389/fgene.2023.1278511. eCollection 2023.
6
A Rare Case of Renal Thrombotic Microangiopathy and Focal Segmental Glomerulosclerosis Secondary to Plasma Cell Leukemia.
Case Rep Hematol. 2023 Feb 18;2023:7803704. doi: 10.1155/2023/7803704. eCollection 2023.
7
Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report.
Cureus. 2022 Dec 20;14(12):e32753. doi: 10.7759/cureus.32753. eCollection 2022 Dec.
8
Monoclonal Gammopathy of Thrombotic Significance.
Cancers (Basel). 2023 Jan 12;15(2):480. doi: 10.3390/cancers15020480.
9
Glomerulonephritis: immunopathogenesis and immunotherapy.
Nat Rev Immunol. 2023 Jul;23(7):453-471. doi: 10.1038/s41577-022-00816-y. Epub 2023 Jan 12.
10
Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.
Front Immunol. 2022 Sep 12;13:903315. doi: 10.3389/fimmu.2022.903315. eCollection 2022.
本文引用的文献
1
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Nat Rev Nephrol. 2019 Jan;15(1):45-59. doi: 10.1038/s41581-018-0077-4.
2
Complement-dependent, monoclonal gammapathy-associated thrombotic microangiopathy.
Kidney Int. 2017 Aug;92(2):516. doi: 10.1016/j.kint.2017.04.039.
3
Thrombotic microangiopathy associated with monoclonal gammopathy.
Kidney Int. 2017 Mar;91(3):691-698. doi: 10.1016/j.kint.2016.09.045. Epub 2016 Dec 18.
4
Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia.
Oncology (Williston Park). 2011 Sep;25(10):908-14.
5
TTP disease course is independent of myeloma treatment and response.
Am J Hematol. 2010 Apr;85(4):304-6. doi: 10.1002/ajh.21646.
6
Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer.
Oncologist. 2003;8(4):375-80. doi: 10.1634/theoncologist.8-4-375.
Zotero 插件